Progression of Metastasis of Oral Tongue Cancer
Progression of Metastasis of Oral Tongue Cancer
批准号:
7051438
负责人:
Jeffrey Nicholas Myers
金额:
$31.52万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-10 至 2008-04-30
关键词:
actinomycinapoptosisathymic mousebiological signal transductioncell lineclinical researchgenetic transcriptiongenetic translationhuman tissueimmunocytochemistryin situ hybridizationmetastasismicroarray technologyneoplastic processnorthern blottingssquamous cell carcinomasurvivintongue neoplasmswestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Current theories of tumor progression postulate that normal epithelial cells need to acquire mechanisms to evade apoptosis and acquire several other essential biologic properties in order to progress to invasive and metastatic tumors. Programmed cell death after detachment from the basement membrane is known as an oikis. The central hypothesis is of this application is that evasion of anoikis is associated with local tumor progression, and metastasis of squamous cell carcinoma of the oral cavity (SCCOC). Four individual inter-related hypotheses would be evaluated in four separate Aims. The first hypothesis is that anoikis-resistance is necessary but not sufficient for tumor progression, including local growth as well as regional and distant metastases. To demonstrate that anoikis-resistance is associated with disease progression, we will investigate the growth of human SCCOC cell lines in an orthotopic, nude mouse model that we have developed. Human SCCOC cell lines and anoikis resistant cells that have been selected in vitro will be injected into the tongues of nude mice, and these mice will be examined for tumor growth, length of survival and the presence of regional nodal and distant metastases. Conversely, we will demonstrate the anoikis resistance of cell lines that we have derived from in vivo orthotopic selection of regional and distant metastases by quantitation of their survival in suspension culture. The second hypothesis guiding the next Aim of this application is that the pro-survival signals mediating anoikis resistance are not constitutive but rather are induced by the process of cell detachment data to date, suggest that this is due to the induction of apoptosis suppression that is far downstream, as we have found that cell detachment induces resistance to multiple forms of apoptosis induction by both the extrinsic and intrinsic pathways. The third hypothesis is that the BiR containing proteins c-IAP-2, survivin, and XIAP are mediating the detachment-induced survival in the face of multiple forms of apoptotic signaling. This hypothesis will be tested by increasing and decreasing expression or activity of either of these two regulatory molecules in5cell lines and examining the resultant cell lines for their anoikis resistance in vitro and their tumorigenicity and metastatic potential in vivo. The final hypothesis is that expression of the downstream apoptotic regulatory molecules c-IAP-2, survivin, and XIAP is associated with tumor progression and metastasis in human SCCOC and in an orthotopic model of oral cancer. To demonstrate that these apoptotic regulatory molecules are expressed in human SCCOT tumors and that their expression is linked with poorer clinic pathologic outcomes, archival human SCCOT tumor will be evaluated for expression of these apoptotic regulatory molecules by in situ hybridization and immunhistochemistry. It is anticipated that high expression of apoptotic inhibitory molecules in tumor specimens from patients with poor clinicopathologic outcomes will provide insight into the potential roles of the IAPsas prognostic indicators and/or therapeutic targets. Further support for these roles of IAPs will result from demonstration that increased expression of these molecules leads to more aggressive tumor growth and metastasis in an orthotopic metastatic model of SCCOT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin-Core-001
-
批准号:10942944
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2023
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10767096
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Administrative Core
-
批准号:10518174
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers
-
批准号:10617289
-
项目类别:
-
资助金额:$55.61万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10830565
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10518173
-
项目类别:
-
资助金额:$123.73万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers
-
批准号:10442206
-
项目类别:
-
资助金额:$55.61万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Administrative Core
-
批准号:10707158
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10707142
-
项目类别:
-
资助金额:$117.47万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:9281788
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:8893048
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:9433803
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:8768360
-
项目类别:
-
资助金额:$52.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:9067264
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The 7th International Conference on Head and Neck Cancer
-
批准号:7486677
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2008
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression of Metastasis of Oral Tongue Cancer
-
批准号:7214870
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:8232943
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:8435297
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:8817640
-
项目类别:
-
资助金额:$49.79万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:7656535
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: